Calcineurin A gamma and NFATc3/SRPX2 axis contribute to human embryonic stem cell differentiation. Issue 8 (3rd January 2021)

• Record Type: Journal Article
• Authors: Chen, Hao; Zeng, Yanwu; Shao, Min; Zhao, Hanzhi; Fang, Zhuoqing; Gu, Junjie; Liao, Bing; Jin, Ying
• Is Part Of: Journal of cellular physiology. Volume 236:Issue 8(2021)
• Page Start: 5698
• Page End: 5713
• Publication Date: 2021-01-03
• Subjects: calcineurin A gamma -- hESC differentiation -- NFATc3 -- SRPX2 -- uPAR; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.30255
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: Our understanding of signaling pathways regulating the cell fate of human embryonic stem cells (hESCs) is limited. Calcineurin‐NFAT signaling is associated with a wide range of biological processes and diseases. However, its role in controlling hESC fate remains unclear. Here, we report that calcineurin A gamma and the NFATc3/SRPX2 axis control the expression of lineage and epithelial–mesenchymal transition (EMT) markers in hESCs. Knockdown of PPP3CC, the gene encoding calcineurin A gamma, or NFATC3, downregulates certain markers both at the self‐renewal state and during differentiation of hESCs. Furthermore, NFATc3 interacts with c‐JUN and regulates the expression of SRPX2, the gene encoding a secreted glycoprotein known as a ligand of uPAR. We show that SRPX2 is a downstream target of NFATc3. Both SRPX2 and uPAR participate in controlling expression of lineage and EMT markers. Importantly, SRPX2 knockdown diminishes the upregulation of multiple lineage and EMT markers induced by co‐overexpression of NFATc3 and c‐JUN in hESCs. Together, this study uncovers a previously unknown role of calcineurin A gamma and the NFATc3/SRPX2 axis in modulating the fate determination of hESCs.